Skip to main content

EDITORIAL article

Front. Psychiatry, 07 December 2022
Sec. Mood Disorders
This article is part of the Research Topic Interventions based on New Technologies for the Management of Mood Disorders View all 6 articles

Editorial: Interventions based on new technologies for the management of mood disorders

\nAlejandro Porras-Segovia,
Alejandro Porras-Segovia1,2*Inmaculada Peuelas-CalvoInmaculada Peñuelas-Calvo3Benedicte NobileBenedicte Nobile4Luis Gutirrez-RojasLuis Gutiérrez-Rojas5
  • 1Mental Health Research Group, Health Research Institute Foundation Jimenez Diaz (IIS-FJD), Madrid, Spain
  • 2Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom
  • 3Department of Psychiatry, Hospital 12 de Octubre, Madrid, Spain
  • 4INSERM, Montpellier, France
  • 5Department of Psychiatry, University of Granada, Granada, Spain

Mood disorders are highly prevalent mental conditions that cause significant disability worldwide (1). They are strongly associated with physical comorbidities, such as cancer and cardiovascular diseases, and with other mental conditions, such as anxiety disorders, substance abuse or increased risk of suicide. They also generate significant direct and indirect costs (2).

Despite advances in psychopharmacological treatment and psychotherapy over the last decades, treating depression remains a challenge in daily clinical practice. There are many patients who do not respond to treatment, and there are physical barriers to access to the available treatments (3). Therefore, it is crucial to invest in the development of complementary management strategies, which may help to improve the prognosis of mood disorders.

New technologies are making their way into the mental health arena (4). Studies show the effectiveness of several different devices as a supplementary therapy in mental problems such as suicide (57). Their use has been revalued with the COVID-19 pandemic and its blocking periods, compensating for the disruption of face-to-face visits, and helping to maintain continuity of care in mental health. New technologies can continue to help us thanks to their wide availability and versatility.

The goal of this Research Topic is to present studies on therapeutic interventions delivered using new technologies for the management of mood disorders. The potential of these treatments will be discussed, as well as the barriers to their implementation in clinical practice and the developments that are expected in the not distant future.

This Research Topic focus on fronts as diverse as smartphone apps, advances in neuroimaging, transcranial magnetic stimulation, or the use of machine learning.

This Research Topic includes five studies on the use of new technologies and other related devices, systems and techniques applied to the management of mood disorders.

The first of these studies presents the results of the MeMo study, which involves the implementation of a mood monitoring system in young people using a mobile phone application. The authors showed that the use of the app decreased negative mood among participants (Dubad et al.).

The second study consists of an analysis of the publications on the social network Twitter about psychotherapy over the last 11 years in the United States. The authors show that the type of psychotherapy that appears most frequently on this social network is mindfulness, while certain psychotherapies, such as computer-supported therapy, do not appear on the social network, which could be a reflection of the lack of knowledge of these psychotherapy modalities among the general population (Alvarez-Mon et al.).

The third study employs machine learning techniques to detect symptoms of depression and suicide risk through texts extracted from clinical interviews. The authors compared a group of depressed patients with a group of healthy patients and recorded their speech while they responded to a Mini-International Neuropsychiatric Interview. Using machine learning they were able to correctly classify the sample into depressed and non-depressed groups with an area under the curve of 0.9. The classification of suicide risk between high and low within the depressed patients was achieved with an area under the curve of 0.5 (Shin et al.).

The fourth study published in this Research Topic consists of a clinical trial on the use of Tuina therapy and how the results of this treatment can be reflected in changes in the MRI of depressed patients (Tao et al.).

The fifth study to be published explores the use of bilateral repetitive transcranial magnetic stimulation to tackle sleep disorders and Hypothalamic-pituitary-adrenal (HPA) Axis Dysfunction in Subjects with Major Depression. After 4 weeks of treatment, a beneficial effect was found in those patients treated with the intervention (Chen et al.).

These five studies, each one with its different angle, contribute to the growing evidence that new technologies can help us in the management of mood disorders.

Future perspectives in the field include the development of high-quality software and devices, and more accurate analysis techniques, and how to overcome challenges to the implementation of new technologies in everyday clinical practice.

Author contributions

AP-S wrote the manuscript. All authors contributed substantially to the drafting and revision of the manuscript, read, and approved the final version.

Funding

AP-S received funding from the Alicia Koplowitz Foundation.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Gutiérrez-Rojas L, Porras-Segovia A, Dunne H, Andrade-González N, Cervilla JA. Prevalence and correlates of major depressive disorder: a systematic review. Rev Brasileira Psiquiatria. (2020) 42:657–72. doi: 10.1590/1516-4446-2020-0650

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Malhi GS, Mann JJ. Depression. Lancet. (2018) 392:2299–312. doi: 10.1016/S0140-6736(18)31948-2

PubMed Abstract | CrossRef Full Text

3. Touloumis C. The burden and the challenge of treatment-resistant depression. Psychiatrike. (2021) 32:11–4. doi: 10.22365/jpsych.2021.046

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Bucci S, Schwannauer M, Berry N. The digital revolution and its impact on mental health care. Psychol Psychother. (2019) 92:277–97. doi: 10.1111/papt.12222

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Jiménez-Muñoz L, Peñuelas-Calvo I, Díaz-Oliván I, Gutiérrez-Rojas L, Baca-García E, Porras-Segovia A. Suicide prevention in your pocket: A systematic review of ecological momentary interventions for the management of suicidal thoughts and behaviors. Harv Rev Psychiat. (2022) 30:85–99. doi: 10.1097/HRP.0000000000000331

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Molina R, Díaz-Oliván I, Girela B, Moreno M, Jiménez-Muñoz L, Delgado-Gómez D, et al. Video games as a complementary therapy for schizophrenia: A systematic review. J Psychiatr Pract. (2022) 28:143–55. doi: 10.1097/PRA.0000000000000614

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Porras-Segovia A, Díaz-Oliván I, Gutiérrez-Rojas L, Dunne H, Moreno M, Baca-García E. Apps for depression: Are they ready to work? Curr. Psychiat Rep. (2020) 22:11. doi: 10.1007/s11920-020-1134-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: new technologies, mental health, mobile applications, social networks, machine learning

Citation: Porras-Segovia A, Peñuelas-Calvo I, Nobile B and Gutiérrez-Rojas L (2022) Editorial: Interventions based on new technologies for the management of mood disorders. Front. Psychiatry 13:1099947. doi: 10.3389/fpsyt.2022.1099947

Received: 16 November 2022; Accepted: 22 November 2022;
Published: 07 December 2022.

Edited and reviewed by: Michael Maes, Chulalongkorn University, Thailand

Copyright © 2022 Porras-Segovia, Peñuelas-Calvo, Nobile and Gutiérrez-Rojas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alejandro Porras-Segovia, alexposeg@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.